SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Claire McLINTOCK, Tim BRIGHTON, Sanjeev CHUNILAL, Gus DEKKER, Nolan McDONNELL, Simon McRAE, Peter MULLER, Huyen TRAN, Barry N.J. WALTERS, Laura YOUNG, Recommendations for the prevention of pregnancy-associated venous thromboembolism, Australian and New Zealand Journal of Obstetrics and Gynaecology, 2012, 52, 1
  2. 2
    Wing-Hung Tam, Margaret Heung-Ling Ng, Alice Ka-Wah Yiu, Kin-Mang Lau, Gregory Yin-Ming Cheng, Chi-Yin Li, Thrombophilia among Chinese Women with Venous Thromboembolism during Pregnancy, Gynecologic and Obstetric Investigation, 2012, 73, 3, 183

    CrossRef

  3. 3
    Christina S. Han, Michael J. Paidas, Charles J. Lockwood, High Risk Pregnancy, 2011,

    CrossRef

  4. 4
    James A. Airoldi, Maternal-Fetal Evidence Based Guidelines, 2011,

    CrossRef

  5. 5
    C. Boyer-Neumann, Hémostase et grossesse, EMC - Hématologie, 2010, 5, 4, 1

    CrossRef

  6. 6
    Jeanine F. Carbone, Roxane Rampersad, Prenatal Screening for Thrombophilias: Indications and Controversies, Clinics in Laboratory Medicine, 2010, 30, 3, 747

    CrossRef

  7. 7
    Susan Murin, Kathryn Bilello, Lisa Moores, Aaron Holley, Principles of Gender-Specific Medicine, 2010,

    CrossRef

  8. 8
    Leena Hiltunen, Anna Rautanen, Vesa Rasi, Risto Kaaja, Juha Kere, Tom Krusius, Elina Vahtera, Mikko Paunio, An unfavorable combination of factor V Leiden with age, weight, and blood group causes high risk of pregnancy-associated venous thrombosis—a population-based nested case-control study, Thrombosis Research, 2007, 119, 4, 423

    CrossRef

  9. 9
    B Nagy, P Hupuczi, Z Papp, High frequency of methylenetetrahydrofolate reductase 677TT genotype in Hungarian HELLP syndrome patients determined by quantitative real-time PCR, Journal of Human Hypertension, 2007, 21, 2, 154

    CrossRef

  10. 10
    Rainer B Zotz, Andrea Gerhardt, Rüdiger E Scharf, Inherited thrombophilia and gestational venous thromboembolism, Women's Health, 2007, 3, 2, 215

    CrossRef

  11. 11
    Mrinal M Patnaik, Tufia Haddad, Colleen T Morton, Pregnancy and thrombophilia, Expert Review of Cardiovascular Therapy, 2007, 5, 4, 753

    CrossRef

  12. 12
    Andra H. James, Prevention and Management of Venous Thromboembolism in Pregnancy, The American Journal of Medicine, 2007, 120, 10, S26

    CrossRef

  13. 13
    Jennifer Voke, Jane Keidan, Sue Pavord, Neil H. Spencer, Beverley J. Hunt, The management of antenatal venous thromboembolism in the UK and Ireland: a prospective multicentre observational survey, British Journal of Haematology, 2007, 139, 4
  14. 14
    Scott M Nelson, Ian A Greer, Thrombophilia and maternal mortality: risk factors and preventive approaches, Expert Review of Obstetrics & Gynecology, 2007, 2, 4, 477

    CrossRef

  15. 15
    Ian A. Greer, Anticoagulants in Pregnancy, Journal of Thrombosis and Thrombolysis, 2006, 21, 1, 57

    CrossRef

  16. 16
    H. Schinzel, D. Peetz, J. Wiechelt, M. A. Mach, D. Macciella, Die akute heparininduzierte Thrombozytopenie Typ II während der Schwangerschaft, Intensivmedizin und Notfallmedizin, 2006, 43, 1, 12

    CrossRef

  17. 17
    Michelle A. Kominiarek, Judith U. Hibbard, Postpartum Ovarian Vein Thrombosis: An Update, Obstetrical & Gynecological Survey, 2006, 61, 5, 337

    CrossRef

  18. 18
    Scott M. Nelson, Ian A. Greer, Thrombophilia and the Risk for Venous Thromboembolism during Pregnancy, Delivery, and Puerperium, Obstetrics and Gynecology Clinics of North America, 2006, 33, 3, 413

    CrossRef

  19. 19
    C. Boyer-Neumann, Hémostase et grossesse, EMC - Hématologie, 2005, 2, 2, 132

    CrossRef

  20. 20
    Andra H. James, Leo R. Brancazio, Prenatal Screening for Thrombophilia: The Background and the Approach, Gynecologic and Obstetric Investigation, 2005, 60, 1, 47

    CrossRef

  21. 21
    Glade C. Welker, Sandra Lookinland, Mary E. Tiedeman, Renea L Beckstrand, The Role of Genetics in the Risk of Thromboembolism: Prothrombin 20210A and Oral Contraceptive Therapy, Journal of the American Academy of Nurse Practitioners, 2004, 16, 3
  22. 22
    Stephen Sidney, Diana B Petitti, Gerald A Soff, Deborah L Cundiff, Kimberly K Tolan, Charles P Quesenberry, Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives, Contraception, 2004, 70, 1, 3

    CrossRef

  23. 23
    Susan Murin, Lisa Moores, Kathryn L. Bilello, Richard A. Matthay, Principles of Gender-Specific Medicine, 2004,

    CrossRef

  24. 24
    Valerie A. Holmes, Changes in haemostasis during normal pregnancy: does homocysteine play a role in maintaining homeostasis?, Proceedings of the Nutrition Society, 2003, 62, 02, 479

    CrossRef

  25. 25
    Leon Meglič, Mojca Stegnar, Tomaž Milanez, Mojca Božič, Borut Peterlin, Polona Peternel, Živa Novak-Antolič, Factor V Leiden, prothrombin 20210G [RIGHTWARDS ARROW] A, methylenetetrahydrofolate reductase 677C [RIGHTWARDS ARROW] T and plasminogen activator inhibitor 4G/5G polymorphism in women with pregnancy-related venous thromboembolism, European Journal of Obstetrics & Gynecology and Reproductive Biology, 2003, 111, 2, 157

    CrossRef

  26. 26
    Gabriel S Gebhardt, David R Hall, Inherited and acquired thrombophilias and poor pregnancy outcome: should we be treating with heparin?, Current Opinion in Obstetrics and Gynecology, 2003, 15, 6, 501

    CrossRef

  27. 27
    Rainer B Zotz, Andrea Gerhardt, Rüdiger E Scharf, Inherited thrombophilia and gestational venous thromboembolism, Best Practice & Research Clinical Haematology, 2003, 16, 2, 243

    CrossRef

  28. 28
    Meyer-Michel Samama, Roberto A. Rached, Marie-Hélène Horellou, Sandro Aquilanti, Valérie G. Mathieux, Geneviève Plu-Bureau, Ismail Elalamy, Jacqueline Conard, Pregnancy-associated venous thromboembolism (VTE) in combined heterozygous factor V Leiden (FVL) and prothrombin (FII) 20210 A mutation and in heterozygous FII single gene mutation alone, British Journal of Haematology, 2003, 123, 2
  29. 29
    Ian A Greer, Prevention and management of venous thromboembolism in pregnancy, Clinics in Chest Medicine, 2003, 24, 1, 123

    CrossRef

  30. 30
    Ian A Greer, Prevention of venous thromboembolism in pregnancy, Best Practice & Research Clinical Haematology, 2003, 16, 2, 261

    CrossRef

  31. 31
    Ramzi R. Finan, Hala Tamim, Ghada Ameen, Huda E. Sharida, Mooza Rashid, Wassim Y. Almawi, Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population, American Journal of Hematology, 2002, 71, 4
  32. 32
    Marianne Van Rooijen, Katarina Bremme, A family history can display a synergistic effect of atherogenic and prothrombotic risk in pregnancy, Acta Obstetricia et Gynecologica Scandinavica, 2001, 80, 9
  33. 33
    S. J. Harrison, I. Rafferty, M. D. McColl, Management of heparin allergy during pregnancy with danaparoid, Blood Coagulation and Fibrinolysis, 2001, 12, 2, 157

    CrossRef

  34. 34
    I.A Greer, A.J Thomson, Management of venous thromboembolism in pregnancy, Best Practice & Research Clinical Obstetrics & Gynaecology, 2001, 15, 4, 583

    CrossRef

  35. 35
    Ian A. Greer, The acute management of venous thromboembolism in pregnancy, Current Opinion in Obstetrics and Gynecology, 2001, 13, 6, 569

    CrossRef

  36. 36
    John Bonnar, The risk of recurrence of venous thromboembolism is low in untreated pregnant women with a single prior episode, Evidence-based Obstetrics & Gynecology, 2001, 3, 3, 126

    CrossRef

  37. 37
    Michael J. Paidas, Christina S. Han, Nazli Hossain, Charles J. Lockwood, Inherited and Acquired Thrombophilia in Obstetrics,
  38. 38
    Catherine Nelson-Piercy, Ian Greer, Thromboembolic Disease in Pregnancy,